Key insights
- Genpact partners with Parallel Web Systems to integrate AI-native web research API into its enterprise operations, focusing on insurance and sales. The technology automates information search and retrieval, improving efficiency in claims settlements and sales intelligence. Positive earnings revisions by analysts suggest confidence in Genpact's AI-driven strategy, potentially signaling a modest positive outlook for the stock.

NEW YORK and PALO ALTO, Calif. - Genpact (NYSE:G) announced today a partnership with Parallel Web Systems to integrate the startup’s AI-native web research API into its enterprise operations. The $6.4 billion professional services company trades at a P/E ratio of 12, and according to InvestingPro analysis, appears undervalued relative to its Fair Value—placing it among companies on the Most Undervalued list.
The partnership focuses on automating information search and retrieval processes in insurance and sales operations, according to a press release statement. Parallel’s API technology enables AI agents to conduct web research and retrieve real-time information with source citations.
Genpact is deploying the technology in two primary applications. In insurance, the company uses Parallel’s Task API for automated pricing of like-kind-and-quality replacements in contents claims settlements. The system, called Property Contents Pricing AI Assist, is in production with two of the top 10 U.S. property and casualty insurers. Genpact reports the system has achieved 55% touchless processing and a 50% reduction in cycle time.
In sales operations, Genpact uses the API for Meeting Assist, a system that automates research on clients and prospects. The tool is deployed within Genpact’s field organization to provide account intelligence and business insights.The technology investments come as Genpact generated $5.08 billion in revenue over the last twelve months with 6.6% growth. InvestingPro Tips reveal that 7 analysts have revised their earnings upwards for the upcoming period, suggesting confidence in the company’s AI-driven strategy. The platform tracks 10 additional ProTips for Genpact, available to subscribers.
Parallel’s API provides access to current web information beyond the training data limitations of large language models, including real-time news and market data. The technology includes source traceability and confidence scoring features.
"By combining Genpact’s industry and domain expertise with Parallel’s groundbreaking AI capabilities, we are poised to deliver exceptional value to clients," said Sanjeev Vohra, Chief Technology & Innovation Officer at Genpact.
Parag Agrawal, Founder and CEO of Parallel Web Systems, said the API is designed for encoding business rules into automated web research workflows.
Parallel Web Systems is a Silicon Valley startup that provides web data infrastructure for AI agents through its API platform.For investors seeking deeper analysis, Genpact is among the 1,400+ US equities covered by InvestingPro’s comprehensive Pro Research Reports, which transform complex Wall Street data into clear, actionable intelligence through intuitive visuals and expert analysis.
In other recent news, Genpact Limited’s fourth-quarter 2025 earnings exceeded market expectations, reporting an earnings per share (EPS) of $0.97 compared to the forecasted $0.94. The company’s revenue also surpassed projections, reaching $1.32 billion against an anticipated $1.31 billion. Despite these positive financial results, several analyst firms have adjusted their price targets for Genpact. BMO Capital reduced its price target to $44 while maintaining a Market Perform rating, citing solid operational growth and margin expansion. Needham also lowered its price target to $50 but kept a Buy rating, noting the strong performance of Genpact’s Advanced Technology Solutions segment, which grew 15.7% year-over-year. Jefferies decreased its price target to $45 from $56, maintaining a Buy rating, with revenues meeting their expectations and margins surpassing forecasts. These developments reflect ongoing adjustments in analyst outlooks despite Genpact’s recent financial performance exceeding expectations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.